Abstract
PharmaDM was founded end 2000 as a spin-off from three European universities (Oxford, Aberystwyth, and Leuven) that participated in two subsequent EC projects on Inductive Logic Programming (ILP I-II, 1992-1998). Amongst the projects highlights was a series of publications that demonstrated the added-value of ILP in applications related to the drug discovery process. The mission of PharmaDM is to build on those promising results, including software modules developed at the founding universities (i.e., Aleph, Tilde, Warmr, ILProlog), and develop a profitable ILP based data mining product customised to the needs of drug discovery researchers. Technology development at PharmaDM is mostly based on “demand pull”, i.e., driven by user requirements. In this presentation I will look at the way ILP technology at PharmaDM has evolved over the past four years and the user feedback that has stimulated this evolution.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Dehaspe, L. (2004). From Promising to Profitable Applications of ILP: A Case Study in Drug Discovery. In: Camacho, R., King, R., Srinivasan, A. (eds) Inductive Logic Programming. ILP 2004. Lecture Notes in Computer Science(), vol 3194. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-30109-7_3
Download citation
DOI: https://doi.org/10.1007/978-3-540-30109-7_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22941-4
Online ISBN: 978-3-540-30109-7
eBook Packages: Springer Book Archive